VoxelLTS:0QDB 97 Days Payable is 47.35 as of Mar. 2026, which is 27% below its 10-year median of 65.21. GuruFocus rates LTS:0QDB with a GF Score™ of 97/100 and a GF Value™ of zł128.03. The stock has 2 warning signs investors should review. Among 190 Medical Diagnostics & Research companies, Voxel ranks worse than 52.63% on this metric.
Voxel's average Accounts Payable for the
three
months ended in Mar. 2026 was zł55.5 Mil. Voxel's Cost of Goods Sold for the
three
months ended in Mar. 2026 was zł107.0 Mil.
Hence, Voxel's Days Payable for the
three
months ended in Mar. 2026 was 47.35.
The historical rank and industry rank for Voxel's Days Payable or its related term are showing as below:
LTS:0QDB'
s Days Payable Range Over the Past 10 Years
Min: 55.39 Med: 65.21 Max: 133.23
Current: 62.98
During the past 13 years, Voxel's highest Days Payable was 133.23. The lowest was 55.39. And the median was 65.21.
LTS:0QDB's Days Payable is ranked worse than 52.63% of 190
companies
in the Medical Diagnostics & Research industry
Industry Median: 67.275
vs LTS:0QDB: 62.98
Voxel's Days Payable
declined
from Mar. 2025 (51.26) to Mar. 2026 (47.35).
It may suggest that Voxelaccelerated paying its suppliers.
Voxel Days Payable Related Terms
Voxel Days Payable Historical Data
* Premium members only.
The historical data trend for Voxel's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LTS:0QDB vs TMO, DHR, IDXX: Days Payable Comparison
For the Diagnostics & Research subindustry, Voxel's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Voxel Days Payable vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Voxel's Days Payable distribution charts can be found below:
* The bar in red indicates where Voxel's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Voxel's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Voxel (LTS:0QDB) has a Days Payable of 47.35 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Voxel and its competitors. This is 27% below median its historical median of 65.21. Over the past decade, Voxel's Days Payable has ranged from 55.39 to 133.23. According to the industry distribution chart, Voxel ranks #100 out of 190 companies in the Medical Diagnostics & Research industry, placing it in the top 52.6%.
Is Voxel's Days Payable too high?
Voxel's current Days Payable of 47.35 is 27% below median its 10-year median of 65.21. Over the past 10 years, this metric has ranged from a low of 55.39 to a high of 133.23. The Medical Diagnostics & Research industry median Days Payable is 67.28. Voxel's value of 47.35 is 29.6% below this industry median. Based on the distribution chart, Voxel ranks #100 out of 190 companies in the Medical Diagnostics & Research industry, which is below the industry midpoint. Overall, Voxel has a GF Score™ of 97/100, reflecting its overall financial health beyond just this single metric.
How does Voxel's Days Payable compare to TMO and DHR?
According to the Medical Diagnostics & Research industry distribution chart, Voxel ranks #100 out of 190 companies for Days Payable. This places Voxel in the lower half of its industry. The industry median Days Payable is 67.28. Voxel's value of 47.35 is 29.6% below this benchmark. Historically, Voxel's own Days Payable has ranged from 55.39 to 133.23 over the past decade. While the company's 10-year median is 65.21 vs. the industry median of 67.28, Voxel has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Diagnostics & Research company?
The median Days Payable among Medical Diagnostics & Research companies is 67.28, based on 190 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Voxel's current Days Payable of 47.35 is 29.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Voxel and its competitors. For the Medical Diagnostics & Research industry, the median Days Payable is 67.28 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Voxel's current Days Payable is 47.35, which is 27% below median its own 10-year median of 65.21. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Voxel stock overvalued right now?
Voxel (LTS:0QDB) has a current Days Payable of 47.35. The stock's GF Value™ is zł128.03, compared to a current price of zł109.00 — trading 14.9% below its estimated fair value. The current Days Payable is 47.35, which is 27% below median its 10-year median of 65.21 and 29.6% below the Medical Diagnostics & Research industry median of 67.28. Voxel's overall GF Score™ is 97/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Voxel (LTS:0QDB), the current Days Payable is 47.35 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Voxel (LTS:0QDB) Overvalued in 2026?
Based on GuruFocus' analysis, Voxel stock appears to be undervalued.
The current stock price of zł109.00 is trading 14.9% below its estimated GF Value™ of zł128.03.
Key valuation signals for LTS:0QDB:
Days Payable: 47.35 (27% below median its 10-year median of 65.21)
GF Value™: zł128.03 vs. price of zł109.00 (14.9% below fair value)
Industry Position: 29.6% below the Medical Diagnostics & Research median (#100 of 190)
No single metric tells the full story. See the LTS:0QDB stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Voxel SA is a network of diagnostic imaging laboratories created for patients and to increase access to high-quality tests. The company operates diagnostic imaging centers and laboratories and provides several services such as magnetic resonance imaging, computed tomography and positron emission tomography. It has 33 specialised laboratories in 21 cities throughout Poland.
97GF Score
Get the complete analysis for LTS:0QDB
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0QDB has been successfully added to your 
